Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital of GuangXi Medical UniversityNo recent work listed

Guoqing Ouyang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0130-7958; OpenAlex author ID A5084796212. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: 1 paper

Papers 3

  1. Identification of a novel cuproptosis-related pattern and its tumor microenvironment infiltration characteristics in pancreatic cancer First author DOI 10.21203/rs.3.rs-3215150/v1↗
  2. Efficacy and safety of gemcitabine-capecitabine combination therapy for pancreatic cancer: A systematic review and meta-analysis of randomized controlled trial… Co-author DOI 10.1097/md.0000000000027870↗
  3. Gemcitabine plus cisplatin versus gemcitabine alone in the treatment of pancreatic cancer: a meta-analysis. Co-author DOI 10.1186/s12957-016-0813-9↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Guozhen Huang · 1 shared paper, 2023 · strength 0.19
  2. Guandou Yuan · 1 shared paper, 2023 · strength 0.19
  3. Songqing He · 1 shared paper, 2023 · strength 0.19
  4. Guangdong Pan · 1 shared paper, 2021 · strength 0.15
  5. Xiongying Miao · 1 shared paper, 2016 · strength 0.07
  6. Yu Wen · 1 shared paper, 2016 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.